Thomas B. Berg

Thomas B. Berg

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 470 publications

Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].

Corrigendum to "Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts" [J Hepatol 85 (2026) 91-105].

Journal: Journal of hepatology

Published: July 25, 2026

Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842].

Corrigendum to: "HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers" [JHEP Reports 5 (2023) 100842].

Journal: JHEP reports : innovation in hepatology

Published: July 08, 2026

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

When Biology Pushes Back: Lessons From HBsAg-Targeting Therapies in Hepatitis Delta.

Journal: Journal of hepatology

Published: May 25, 2026

Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)

Hyperlipasemia following therapy with direct antiviral drugs in patients with chronic hepatitis C virus infection - data from the German Hepatitis C Registry (DHC-R)

Journal: Zeitschrift fur Gastroenterologie

Published: April 22, 2026

Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-Registry.

Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease - Data from the German SLD-Registry.

Journal: Zeitschrift fur Gastroenterologie

Published: March 24, 2026

Imaging biomarkers of liver hypertrophy after portal vein embolization in patients with liver tumors: cholestasis, arterial hyperperfusion, and splenic response.

Imaging biomarkers of liver hypertrophy after portal vein embolization in patients with liver tumors: cholestasis, arterial hyperperfusion, and splenic response.

Journal: Abdominal radiology (New York)

Published: March 16, 2026

Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization - Retrospective Single Center Analysis.

Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization - Retrospective Single Center Analysis.

Journal: Journal of gastrointestinal cancer

Published: February 26, 2026

Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD.

Stage-dependent dynamics of Apolipoprotein C3 across the spectrum of MASLD.

Journal: PloS one

Published: February 11, 2026

Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity.

Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation Capacity.

Journal: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Published: February 06, 2026

Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Journal: Ultrasound in medicine & biology

Published: December 16, 2025

Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.

Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.

Journal: Zeitschrift fur Gastroenterologie

Published: December 09, 2025

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort.

Journal: Journal of hepatology

Published: November 24, 2025

Showing 1-12 of 470

Last Updated: 09/26/2026